IAMA Therapeutics to Showcase NKCC1 Inhibitor Research at the 37th ECNP Congress

Milan, Italy — 21–24 September 2024 — IAMA Therapeutics is headed to the 37th European College of Neuropsychopharmacology (ECNP) Congress, Europe’s premier forum for brain research and clinical innovation. Throughout the four‑day meeting in Milan, our scientists will present new pre‑clinical and translational data on next‑generation NKCC1 inhibitors aimed at treating a spectrum of neurological disorders.